Literature DB >> 27815390

Kv1.3 Channels Mark Functionally Competent CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer.

Ameet A Chimote1, Peter Hajdu1, Alexandros M Sfyris1, Brittany N Gleich1, Trisha Wise-Draper2, Keith A Casper3, Laura Conforti4.   

Abstract

Tumor-infiltrating lymphocytes (TIL) are potent mediators of an antitumor response. However, their function is attenuated in solid tumors. CD8+ T-cell effector functions, such as cytokine and granzyme production, depend on cytoplasmic Ca2+, which is controlled by ion channels. In particular, Kv1.3 channels regulate the membrane potential and Ca2+ influx in human effector memory T (TEM) cells. In this study, we assessed the contribution of reduced Kv1.3 and Ca2+ flux on TIL effector function in head and neck cancer (HNC). We obtained tumor samples and matched peripheral blood from 14 patients with HNC. CD3+ TILs were composed of 57% CD4+ (82% TEM and 20% Tregs) and 36% CD8+ cells. Electrophysiology revealed a 70% reduction in functional Kv1.3 channels in TILs as compared with peripheral blood T cells from paired patients, which was accompanied by a decrease in Ca2+ influx. Immunofluorescence analysis showed that CD8+ TILs expressing high Kv1.3 preferentially localized in the stroma. Importantly, high expression of Kv1.3 correlated with high Ki-67 and granzyme B expression. Overall, these data indicate that defective Kv1.3 channels and Ca2+ fluxes in TILs may contribute to reduced immune surveillance in HNC. Cancer Res; 77(1); 53-61. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27815390      PMCID: PMC5215046          DOI: 10.1158/0008-5472.CAN-16-2372

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

Review 1.  Looking through ion channels: recharged concepts in T-cell signaling.

Authors:  György Panyi; György Vámosi; Andrea Bodnár; Rezso Gáspár; Sándor Damjanovich
Journal:  Trends Immunol       Date:  2004-11       Impact factor: 16.687

2.  Immune surveillance against a solid tumor fails because of immunological ignorance.

Authors:  A F Ochsenbein; P Klenerman; U Karrer; B Ludewig; M Pericin; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 3.  Ion channels in innate and adaptive immunity.

Authors:  Stefan Feske; Heike Wulff; Edward Y Skolnik
Journal:  Annu Rev Immunol       Date:  2015       Impact factor: 28.527

Review 4.  Ion channels and transporters in lymphocyte function and immunity.

Authors:  Stefan Feske; Edward Y Skolnik; Murali Prakriya
Journal:  Nat Rev Immunol       Date:  2012-06-15       Impact factor: 53.106

Review 5.  Signalling to transcription: store-operated Ca2+ entry and NFAT activation in lymphocytes.

Authors:  Yousang Gwack; Stefan Feske; Sonal Srikanth; Patrick G Hogan; Anjana Rao
Journal:  Cell Calcium       Date:  2007-06-18       Impact factor: 6.817

Review 6.  Clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers.

Authors:  Sebastian P Wallis; Nicholas D Stafford; John Greenman
Journal:  Head Neck       Date:  2014-07-10       Impact factor: 3.147

Review 7.  Immune infiltration in human tumors: a prognostic factor that should not be ignored.

Authors:  F Pagès; J Galon; M-C Dieu-Nosjean; E Tartour; C Sautès-Fridman; W-H Fridman
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

8.  Effects of changes in extracellular pH and potassium concentration on Kv1.3 inactivation.

Authors:  Sándor Somodi; Péter Hajdu; Rezso Gáspár; György Panyi; Zoltán Varga
Journal:  Eur Biophys J       Date:  2008-01-24       Impact factor: 1.733

Review 9.  The tumor microenvironment and its role in promoting tumor growth.

Authors:  T L Whiteside
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

10.  Trial watch: Prognostic and predictive value of the immune infiltrate in cancer.

Authors:  Laura Senovilla; Erika Vacchelli; Jerome Galon; Sandy Adjemian; Alexander Eggermont; Wolf Hervé Fridman; Catherine Sautès-Fridman; Yuting Ma; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

View more
  18 in total

Review 1.  Ion Channel Dysregulation in Head and Neck Cancers: Perspectives for Clinical Application.

Authors:  Nagore Del-Río-Ibisate; Rocío Granda-Díaz; Juan P Rodrigo; Sofía T Menéndez; Juana M García-Pedrero
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

2.  Cm28, a scorpion toxin having a unique primary structure, inhibits KV1.2 and KV1.3 with high affinity.

Authors:  Muhammad Umair Naseem; Edson Carcamo-Noriega; José Beltrán-Vidal; Jesus Borrego; Tibor G Szanto; Fernando Z Zamudio; Gustavo Delgado-Prudencio; Lourival D Possani; Gyorgy Panyi
Journal:  J Gen Physiol       Date:  2022-06-14       Impact factor: 4.000

3.  A defect in KCa3.1 channel activity limits the ability of CD8+ T cells from cancer patients to infiltrate an adenosine-rich microenvironment.

Authors:  Ameet A Chimote; Andras Balajthy; Michael J Arnold; Hannah S Newton; Peter Hajdu; Julianne Qualtieri; Trisha Wise-Draper; Laura Conforti
Journal:  Sci Signal       Date:  2018-04-24       Impact factor: 8.192

Review 4.  Novel "Elements" of Immune Suppression within the Tumor Microenvironment.

Authors:  Devikala Gurusamy; David Clever; Robert Eil; Nicholas P Restifo
Journal:  Cancer Immunol Res       Date:  2017-06       Impact factor: 11.151

5.  Potassium channels of T lymphocytes take center stage in the fight against cancer.

Authors:  Laura Conforti
Journal:  J Immunother Cancer       Date:  2017-01-17       Impact factor: 13.751

Review 6.  Immuno-Oncology: Emerging Targets and Combination Therapies.

Authors:  Henry T Marshall; Mustafa B A Djamgoz
Journal:  Front Oncol       Date:  2018-08-23       Impact factor: 6.244

7.  Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of Kv1.3 potassium channels, AKT and ERK1/2 signaling.

Authors:  Theresa Lowinus; Florian H Heidel; Tanima Bose; Subbaiah Chary Nimmagadda; Tina Schnöder; Clemens Cammann; Ingo Schmitz; Ulrike Seifert; Thomas Fischer; Burkhart Schraven; Ursula Bommhardt
Journal:  Cell Commun Signal       Date:  2019-01-16       Impact factor: 5.712

Review 8.  Review on Biological Characteristics of Kv1.3 and Its Role in Liver Diseases.

Authors:  Junda Liu; Xiong-Wen Lv; Lei Zhang; Hua Wang; Jun Li; Baoming Wu
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

9.  Kv1.3 activity perturbs the homeostatic properties of astrocytes in glioma.

Authors:  Alfonso Grimaldi; Giuseppina D'Alessandro; Maria Amalia Di Castro; Clotilde Lauro; Vikrant Singh; Francesca Pagani; Luigi Sforna; Francesca Grassi; Silvia Di Angelantonio; Luigi Catacuzzeno; Heike Wulff; Cristina Limatola; Myriam Catalano
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

10.  A Compartmentalized Reduction in Membrane-Proximal Calmodulin Reduces the Immune Surveillance Capabilities of CD8+ T Cells in Head and Neck Cancer.

Authors:  Ameet A Chimote; Vaibhavkumar S Gawali; Hannah S Newton; Trisha M Wise-Draper; Laura Conforti
Journal:  Front Pharmacol       Date:  2020-02-28       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.